Plasma lipids in women using progestogen-only oral contraceptives
Article first published online: 23 AUG 2005
DOI: 10.1111/j.1471-0528.1983.tb08966.x
Issue
1471-0528/asset/cover.gif?v=1&s=b4e1d96c46e18c61210d584b63c13ee375cf562b)
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 90, Issue 6, pages 549–552, June 1983
Additional Information
How to Cite
BRIGGS, M. and BRIGGS, M. (1983), Plasma lipids in women using progestogen-only oral contraceptives. BJOG: An International Journal of Obstetrics & Gynaecology, 90: 549–552. doi: 10.1111/j.1471-0528.1983.tb08966.x
Publication History
- Issue published online: 23 AUG 2005
- Article first published online: 23 AUG 2005
- Received 26 August 1982 A ccepted 24 November 1982
- Abstract
- References
- Cited By
Summary. Using a strict protocol, in an attempt to avoid confounding factors, healthy women were assigned at random to a continuous daily dose of either 30 μg levonorgestrel or 350 μg norethisterone. Volunteers were either aged 40–45 years, or were >30 years and 8–12 weeks post partum. Blood plasma lipids and lipoproteins were measured on specimens collected in the fasting state before treatment, then every month during progestogen treatment. After 6 months there was a small increase in plasma triglycerides, especially in older women, and also in a non-lactating younger group. Changes in lipoprotein-cholesterol fractions were insignificant, though there were significant pretreatment differences between the various groups.

1471-0528/asset/BJO_left.gif?v=1&s=0fb87361cdb6be25fdf05019eed6d47f5143f610)
1471-0528/asset/olbannerright.gif?v=1&s=3892ef16ff18d6834c302faf85268a49f5fc588f)